tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP
US Market

GT Biopharma (GTBP) Income Statement

Compare
227 Followers

GT Biopharma Income Statement

Last quarter (Q3 2024), GT Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, GT Biopharma's net income was $-3.41M. See GT Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -4.00K
Operating Expenses
$ 13.58M$ 21.26M$ 57.52M$ 6.76M$ 11.46M
Depreciation and Amortization
$ 13.58M$ 21.26M$ 57.52M$ 4.00K$ 4.00K
EBITDA
$ 5.98M$ 0.00$ 0.00$ -24.98M$ -11.45M
Operating Income
$ -13.58M$ -21.26M$ -57.52M$ -6.76M$ -16.06M
Other Income/Expenses
$ 5.98M$ 373.00K$ -498.00K$ -21.53M$ -22.59M
Pretax Income
$ -7.60M$ -20.88M$ -58.01M$ -28.30M$ -38.65M
Net Income
$ -7.60M$ -20.50M$ -58.69M$ -31.62M$ -40.77M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.64$ -19.30$ -62.54$ -216.29$ -361.49
Diluted EPS
$ -5.64$ -19.30$ -62.54$ -216.29$ -361.49
Weighted Average Shares Outstanding
1.35M 1.06M 938.52K 146.17K 112.80K
Weighted Average Shares Outstanding (Diluted)
1.35M 1.06M 938.52K 146.17K 112.80K
Currency in USD

GT Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis